Invivyd, Inc. SEC filings IVVD

Invivyd, Inc. has 448 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 6, 2026 Dec 31, 2025
10-K Annual report Mar 5, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 7, 2025 Dec 31, 2024
10-K Annual report Mar 20, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 18, 2024 Dec 31, 2023
10-K Annual report Mar 28, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 10, 2023 Dec 31, 2022
10-K Annual report Mar 23, 2023 Dec 31, 2022
10-K/A Amended annual report Apr 29, 2022 Dec 31, 2021
10-K Annual report Mar 31, 2022 Dec 31, 2021

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
IVVD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Haven, CT
SEC filer status
, Emerging growth company
SEC CIK
1832038
Former names
Adagio Therapeutics, Inc. (until Sep 12, 2022)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.